Cargando…

Combined hormonal therapy for advanced breast cancer in postmenopausal patients

Detalles Bibliográficos
Autores principales:	Langecker, P, Lang, W, Blanchett, D, Bailey, P, Scribner, C, Goss, P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300182/ http://dx.doi.org/10.1186/bcr729

Ejemplares similares

Controversies in the hormonal adjuvant therapy of postmenopausal patients
por: Dowsett, M
Publicado: (2009)

Targeting new therapies in combination with hormonal therapies for ER-positive breast cancer
por: Dowsett, M
Publicado: (2005)

Hormones and radiation as risk factors for breast cancer
por: Beral, V
Publicado: (2006)

Growth regulation and steroid hormone resistance in breast cancer
por: Horwitz, KB
Publicado: (2000)

Preoperative hormonal therapy: results and implications
por: Dowsett, M
Publicado: (2005)

Tamoxifen resistance and adjuvant hormone therapy
por: Howell, A
Publicado: (2005)

Pharyngeal enlargement via tongue advancement differs with mandibular advancement therapy response and improves treatment prediction
por: Jugé, L, et al.
Publicado: (2021)

Controversies in hormonal adjuvant therapy for premenopausal patients
por: Howell, A
Publicado: (2009)

Chemoprevention for breast cancer: current status
por: Boyle, P
Publicado: (2004)

Adjuvant therapy of HER2(+ )breast cancer
por: Winer, EP
Publicado: (2009)

Hormone replacement therapy, percent mammographic density and the sensitivity of mammography
por: Kavanagh, AM, et al.
Publicado: (2004)

How safe is growth hormone therapy? SAGhE and beyond
por: Carel, Jean-Claude
Publicado: (2013)

Potential mechanisms whereby estrogens induce breast cancer in women
por: Santen, RJ, et al.
Publicado: (2005)

ATM mutations associated with breast cancer
por: Gatti, RA, et al.
Publicado: (2005)

Design of RESILIENCE: a phase 3 trial comparing capecitabine in combination with sorafenib or placebo for treatment of locally advanced or metastatic HER2-negative breast cancer
por: Baselga, J, et al.
Publicado: (2011)

Is ultrasound axillary staging less accurate in invasive lobular breast cancer than in ductal breast cancer?
por: Sankaye, P, et al.
Publicado: (2012)

TG4010 immunotherapy combined with first-line therapy in advanced non-small cell lung cancer (NSCLC): phase IIb results of the TIME study
por: Quoix, Elisabeth, et al.
Publicado: (2014)

The EGF receptor family as targets for breast cancer therapy
por: Baselga, J
Publicado: (2000)

Predicting response/resistance to endocrine therapy for breast cancer
por: Miller, WR, et al.
Publicado: (2005)

Targeting the cell cycle for prognosis and therapy of breast cancer
por: Keyomarsi, K, et al.
Publicado: (2005)

Adjuvant therapy after preoperative treatment for breast cancer
por: Ciruelos, E
Publicado: (2009)

Menopause and hormone replacement therapy: effects on the immune system, arthritis and bone
por: Carlsten, H, et al.
Publicado: (2004)

Mammographic screening with a breast cancer prevention programme
por: Boyle, P
Publicado: (2004)

Tumour-selective transcriptional targeting for breast cancer gene therapy
por: Hurst, HC
Publicado: (2000)

Aminoglutethimide induced hormone suppression and response to therapy in advanced postmenopausal breast cancer.
por: Harris, A. L., et al.
Publicado: (1983)

Role of the ATM gene in radiation sensitivity, relevance to breast cancer treatment
por: Hall, J, et al.
Publicado: (2000)

Regulated intratumoral expression of IL-12 as a basis for combination therapy in melanoma
por: Nemunaitis, John J, et al.
Publicado: (2014)

Pathological features and patterns of metastatic disease in locally advanced inflammatory and non-inflammatory breast cancer
por: Mvere, MZ, et al.
Publicado: (2009)

Identification of genetic markers of resistance to Artemisinin Combination Therapy in the rodent model Plasmodium chabaudi
por: Rodrigues, Louise A, et al.
Publicado: (2010)

Response to growth hormone therapy and gonadal pathology in 45,X/46,XY females
por: Titmuss, Angela, et al.
Publicado: (2015)

Proteomic approaches to early detection of breast cancer
por: Celis, JE, et al.
Publicado: (2005)

Adjuvant chemotherapy for operable breast cancer: old vs new schema
por: Valagussa, P, et al.
Publicado: (2005)

Two molecular cytogenetic views of breast cancer
por: Gray, J, et al.
Publicado: (2000)

Ultrasound-guided axillary node core biopsy in the staging of newly diagnosed breast cancer
por: Britton, P, et al.
Publicado: (2008)

Differentiation therapy: targeting breast cancer stem cells to reduce resistance to radiotherapy and chemotherapy
por: Roy, R, et al.
Publicado: (2010)

Lessons from TP53 mutations in breast cancers: from carcinogen fingerprints to clinical correlates
por: Hainaut, P, et al.
Publicado: (2000)

Postmenopausal Hormone Therapy and Its Association with Breast Cancer
por: Syal, Arshi, et al.
Publicado: (2020)

Correlations between shear wave elastography and mammographic findings in invasive breast cancer
por: Budak, MJ, et al.
Publicado: (2011)

The role of magnetic resonance imaging as an imaging tool to assess disease status and residual disease in locally advanced breast cancer
por: Cristofanilli, M
Publicado: (2005)

Neratinib, an irreversible pan erB receptor tyrosine kinase inhibitor active for advanced HER2(+ )breast cancer
por: Cortés-Funes, H, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_vcgu3dpuer7tpgd70v1t8suo3r